Brief: Benuvia Signs Agreement To Become Publicly Traded Company Through A Business Combination With Pono Capital Corp

Aerwins Technologies

18/03/2022 10:03

March 18 (Reuters) - 
    * BENUVIA, A LEADING DRUG DEVELOPER FOCUSED ON
PHARMACEUTICAL
CANNABINOIDS, WITH THE FDA APPROVED DRUG SYNDROS®, SIGNS
DEFINITIVE AGREEMENT TO BECOME A PUBLICLY TRADED COMPANY THROUGH
A BUSINESS COMBINATION WITH PONO CAPITAL CORP
    * BENUVIA - TRANSACTION IMPLIES A COMBINED COMPANY PRO FORMA
ENTERPRISE VALUE OF $440 MILLION
    * BENUVIA - EXPECTS TO RECEIVE UP TO $115 MILLION IN
ESTIMATED
GROSS TRANSACTION PROCEEDS ASSUMING NO REDEMPTIONS
    * BENUVIA - NO PIPE TRANSACTION IS EXPECTED AS PART OF
TRANSACTION

Source text for Eikon:  ID:nGNX8MFygc 
Further company coverage:  PONO.O